Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB
Treatment and conditionWhere it standsTrials
Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1